181 related articles for article (PubMed ID: 24018316)
1. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
[TBL] [Abstract][Full Text] [Related]
2. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
[TBL] [Abstract][Full Text] [Related]
3. Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
Vourvahis M; Wang R; Gruener DM; Bruce RD; Haider S; Tawadrous M
Drug Alcohol Depend; 2012 Nov; 126(1-2):183-8. PubMed ID: 22682979
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
[TBL] [Abstract][Full Text] [Related]
5. Effect of raltegravir on the pharmacokinetics of methadone.
Anderson MS; Mabalot Luk JA; Hanley WD; Jin B; Riesenberg RA; Wenning LA; Chodakewitz JA; Wagner JA; Iwamoto M
J Clin Pharmacol; 2010 Dec; 50(12):1461-6. PubMed ID: 20173085
[TBL] [Abstract][Full Text] [Related]
6. The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.
Crauwels HM; van Heeswijk RP; Vandevoorde A; Buelens A; Stevens M; Hoetelmans RM
J Clin Pharmacol; 2014 Feb; 54(2):133-40. PubMed ID: 24203510
[TBL] [Abstract][Full Text] [Related]
7. Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
Song I; Borland J; Chen S; Guta P; Lou Y; Wilfret D; Wajima T; Savina P; Peppercorn A; Castellino S; Wagner D; Hosking L; Mosteller M; Rubio JP; Piscitelli SC
Eur J Clin Pharmacol; 2014 Oct; 70(10):1173-9. PubMed ID: 25146692
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.
Wang X; Cerrone M; Ferretti F; Castrillo N; Maartens G; McClure M; Boffito M
Int J Antimicrob Agents; 2019 Aug; 54(2):202-206. PubMed ID: 31002950
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.
Liu P; Foster G; Labadie R; Somoza E; Sharma A
Antimicrob Agents Chemother; 2007 Jan; 51(1):110-8. PubMed ID: 17074798
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects.
Dooley KE; Sayre P; Borland J; Purdy E; Chen S; Song I; Peppercorn A; Everts S; Piscitelli S; Flexner C
J Acquir Immune Defic Syndr; 2013 Jan; 62(1):21-7. PubMed ID: 23075918
[TBL] [Abstract][Full Text] [Related]
12. Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
Song IH; Borland J; Chen S; Wajima T; Peppercorn AF; Piscitelli SC
Ann Pharmacother; 2015 Jul; 49(7):784-9. PubMed ID: 25862012
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.
Min S; Sloan L; DeJesus E; Hawkins T; McCurdy L; Song I; Stroder R; Chen S; Underwood M; Fujiwara T; Piscitelli S; Lalezari J
AIDS; 2011 Sep; 25(14):1737-45. PubMed ID: 21716073
[TBL] [Abstract][Full Text] [Related]
14. The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects.
Zong J; Borland J; Jerva F; Wynne B; Choukour M; Song I
J Int AIDS Soc; 2014; 17(4 Suppl 3):19584. PubMed ID: 25394090
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment.
Weller S; Borland J; Chen S; Johnson M; Savina P; Wynne B; Wajima T; Peppercorn AF; Piscitelli SC
Eur J Clin Pharmacol; 2014 Jan; 70(1):29-35. PubMed ID: 24096683
[TBL] [Abstract][Full Text] [Related]
16. No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
Ross LL; Song IH; Arya N; Choukour M; Zong J; Huang SP; Eley T; Wynne B; Buchanan AM
BMC Infect Dis; 2016 Jul; 16():347. PubMed ID: 27450277
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers.
Schöller-Gyüre M; van den Brink W; Kakuda TN; Woodfall B; De Smedt G; Vanaken H; Stevens T; Peeters M; Vandermeulen K; Hoetelmans RM
J Clin Pharmacol; 2008 Mar; 48(3):322-9. PubMed ID: 18195053
[TBL] [Abstract][Full Text] [Related]
18. Effect of ritonavir-boosted danoprevir, a potent hepatitis C virus protease inhibitor, on the pharmacokinetics of methadone in healthy subjects undergoing methadone maintenance therapy.
Moreira SA; Morcos PN; Navarro MT; Bech N; Smith PF; Brennan BJ
Pharmacotherapy; 2014 Mar; 34(3):220-6. PubMed ID: 23946152
[TBL] [Abstract][Full Text] [Related]
19. Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
Song I; Borland J; Chen S; Peppercorn A; Wajima T; Piscitelli SC
Antimicrob Agents Chemother; 2014 Nov; 58(11):6696-700. PubMed ID: 25155604
[TBL] [Abstract][Full Text] [Related]
20. Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.
Chen S; Min SS; Peppercorn A; Borland J; Lou Y; Song I; Fujiwara T; Piscitelli SC
Pharmacotherapy; 2012 Apr; 32(4):333-9. PubMed ID: 22422361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
